Concurrent proinflammatory and apoptotic activity of a Helicobacter pylori protein (HP986) points to its role in

Ayesha Alvi1, Suhail A Ansari, Nasreen Z Ehtesham

  • 1Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, India.

Plos One
|July 27, 2011
PubMed

Insights

Helicobacter pylori gene HP986 produces a protein that triggers inflammation and macrophage apoptosis. This suggests HP986 may help the bacterium persist in the stomach, contributing to peptic ulcers and gastric cancer.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Helicobacter pylori infection causes gastroduodenal inflammation, peptic ulcers, and gastric cancer.
  • The mechanisms enabling H. pylori persistence within the gastric niche remain unclear.
  • Activated macrophages are crucial in the innate immune response to H. pylori.

Purpose of the Study:

  • To characterize the function of the previously uncharacterized H. pylori gene HP986.
  • To investigate the role of HP986 in H. pylori pathogenesis and host immune response.

Main Methods:

  • Expression and purification of recombinant HP986 protein (rHP986).
  • Assessing humoral immune responses in infected individuals.
  • Evaluating the effects of rHP986 on cultured human macrophages, including cytokine induction (TNF-α, IL-8) and NF-κB translocation.
  • Investigating macrophage apoptosis via Fas and TNFR1 pathways.
  • Computational and experimental analysis of HP986-TNFR1 interaction.

Main Results:

  • rHP986 is a biologically active ~29 kDa protein eliciting strong humoral immune responses in diseased individuals.
  • rHP986 induces TNF-α and IL-8 production in macrophages, coupled with NF-κB activation.
  • rHP986 triggers macrophage apoptosis through a Fas-mediated pathway, involving TNFR1 and Fas expression.
  • HP986 interacts with TNFR1.

Conclusions:

  • HP986 protein plays a significant role in H. pylori pathogenesis.
  • HP986 likely contributes to bacterial survival by inducing inflammation and promoting macrophage apoptosis, aiding niche establishment.
  • Understanding HP986's function offers insights into H. pylori persistence and associated diseases.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...